Top Pharmaceutical Contract Manufacturing Companies

The growing trend in the pharmaceutical contract manufacturing industry is to use contract manufacturing services to cut costs, scale production faster. As pharmaceutical manufacturers become more complex, pharmaceutical companies are increasingly turning to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that offer specialized services for complex drug compounds. In addition, an increasing number of new therapies are coming on the market, and pharmaceutical manufacturers are looking to contract manufacture for these products to answer both the demand for international markets and the need for improved efficiency in the manufacture of medications.

Industry Overview

According to SkyQuest Technology “Pharmaceutical Contract Manufacturing Market By Services (Pharmaceutical Manufacturing Services, Drug Development Services, Biologics Manufacturing Services, Packaging & Labelling Services, Fill-finish Services, Other Services), By End User, By Region- Industry Forecast 2025-2032,” Global Pharmaceutical Contract Manufacturing Market is projected to grow at a CAGR of over 5.9% by 2032, on account of urgent need for automating quantified data. The combination of a strong international demand for pharmaceuticals (driven by aging populations, the growing number of chronic disease patients, and an expanding global market for generic pharmaceuticals) with increased regulatory oversight (e.g., GMP regulations). As a result, many pharmaceutical firms are turning to contract manufacturers to help them lower their costs and improve their ability to manufacture their products more efficiently and quickly.

Top 10 Global Pharmaceutical Contract Manufacturing Companies

1. Lonza Group.

Lonza Group is one of the largest and most diverse contract development and manufacturing organizations (CDMO) in the world with capabilities covering small molecule (APIs), biologics, cell/gene therapies, as well as advanced biomanufacturing technology. Lonza Group has extensive capabilities for both biologic and non-biologic product development/manufacturing and has the most comprehensive development/manufacturing solutions available today. Additionally, Lonza Group has industry-leading mammalian cell culture capabilities and viral vector manufacturing capabilities, which allow them to offer end-to-end integrated development and manufacturing services.

2. Thermo Fisher Scientific

Thermo Fisher Scientific's Patheon is a leading provider of outsourced pharmaceutical development and manufacturing services, both biologic and small molecule. Thermo Fisher Scientific's extensive integrated analytical, research, and technology platforms enable Patheon to provide complete, integrated development services starting from pre-clinical formulation through to commercial manufacturing.

3. Catalent Pharma Solutions

Catalent is one of the largest contract development and manufacturing organizations (CDMO) in the world, with advanced delivery technologies, including softgel capsules, Zydis tablets, and an extensive injectable formulation platform. Catalent has developed a wide range of clinical supply services, while expanding into the high-growth area of cell and gene therapy manufacturing through a number of acquisitions. Catalent's dedication to innovation, expertise in the various dosage forms of drug delivery, quick-to-market capabilities, makes them a preferred partner for developing complex products.

4. Samsung Biologics

Samsung Biologics has risen to prominence as a major player within the biotechnology sector due to its explosive growth as one of the world's leading contract development and manufacturing organizations (CDMOs) for biologics to its enormous production capabilities, highly sophisticated manufacturing facilities, and robust customer service capabilities. In addition to traditional monoclonal antibodies and biosimilars, Samsung Biologics provides full-service contract develop and manufacture of next-generation biologics.

5. WuXi Biologics

WuXi Biologics is a leading contract development and manufacturing organization (CDMO) based in China, having developed a complete range of capabilities for biologics from research through commercialization. WuXi's proprietary "follow-the-molecule" model allows the company to support the complete biologics life cycle seamlessly from start to end.

6. Siegfried Holding AG

Based in Switzerland and widely regarded as one of the premier contract development and manufacturing organization (CDMO), Siegfried specializes in synthesizing custom chemicals as well as producing APIs and drug products. With an extensive history of developing small-molecules for a number of pharmaceutical companies and high levels of compliance with the various international regulatory bodies with which it is involved, Siegfried has built a strong reputation within the pharmaceutical industry.

7. Recipharm AB

Recipharm is a global contract development and manufacturing organization (CDMO) headquartered in Sweden, providing contract manufacture for an extensive range of dosage forms (including sterile injectables, inhalation products, and oral solids), as well as pharmaceutical development, packaging, and regulatory support.

8. FUJIFILM Diosynth Biotechnologies

As a leader in the advanced therapeutic manufacturing and biologic sectors, FUJIFILM Diosynth Biotechnologies provides specialized manufacturing services for the production of advanced therapy products including recombinant proteins, viral vectors, and gene therapy. The company's process development and bioprocessing technology allow FUJIFILM Diosynth to assist customers in every step of the process from early phase through large-scale production.

9.BioXcellence

BioXcellence offers a high level of expertise in both microbial and mammalian cell culture systems as a contract manufacturing organization (CMO) to the biopharmaceutical industry. With this breadth of knowledge and expertise, BioXcellence can assist clients throughout the entire process, from pre-clinical development through large-scale commercial manufacturing, in a highly compliant manner with the highest regulatory standards to the company’s extensive and decades-long experience delivering high-quality biopharmaceuticals. BioXcellence operates numerous global sites and possesses significant bioprocess innovation capabilities, making it a proven CMO for the manufacture of complex biologics and biosimilars in all major international markets.

10. MilliporeSigma (Formerly Merck KGaA)

MilliporeSigma (Merck KGaA), the life sciences division of Merck KGaA, offers an extensive range of specialized contract manufacturing organization (CMO) services specifically designed for the development of biologic drug products.

Other Leading Global Pharmaceutical Contract Manufacturing Companies

1. Aenova Group
 2. AbbVie Contract Manufacturing
 3. Baxter BioPharma Solutions
 4. Piramal Pharma Solutions
 5. Almac Group
 6. Famar Healthcare Services
 7. Thermo Fisher Scientific
 8. Cambrex Corporation
 9. Evonik Health Care
 10. Jubilant Pharmova
 11. CordenPharma International
 12. AMRI

Conclusion

The global pharmaceutical contract manufacturing market is expected to continue to grow as pharmaceutical companies pursue the benefits of outsourcing through increased production efficiency, reduced costs, and the ability to focus on R&D and commercialization. The increasing demand for complex biologics, biosimilars, and personalized medicines will further promote the dependence on CDMOs with advanced technology and regulatory knowledge. As the pharmaceutical industry relies more on outsourcing to meet the demand for global drug products, CMOs and CDMOs will become increasingly important in guaranteeing quality, scalability, and timely delivery of pharmaceuticals. Continuous investments, ongoing technology improvements, and continued growth in global capacity will maintain this market as an important component of the modern global pharmaceutical supply chain.